A detailed history of Ruedi Wealth Management, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ruedi Wealth Management, Inc. holds 8 shares of BIO stock, worth $2,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 17 52.94%
Holding current value
$2,688
Previous $4.64 Million 42.34%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$263.97 - $344.64 $2,375 - $3,101
-9 Reduced 52.94%
8 $2.68 Million
Q2 2024

Jul 17, 2024

BUY
$268.26 - $339.48 $4,560 - $5,771
17 New
17 $4.64 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.28B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ruedi Wealth Management, Inc. Portfolio

Follow Ruedi Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruedi Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ruedi Wealth Management, Inc. with notifications on news.